Outlook Therapeutics, Inc. (OTLK)
NASDAQ·Healthcare·Biotechnology
$1.02
+11.74%
Mkt Cap $11.72M
Analyst Ratings
Buy
2
Hold
3
Sell
0
Price Target (2 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
-2.0%
Consensus $1.00 vs current $1.02
NASDAQ·Healthcare·Biotechnology
$1.02
+11.74%
Mkt Cap $11.72M
Buy
2
Hold
3
Sell
0
Price Target (2 analysts)
$1.00
Range $1.00 – $1.00
-2.0%
Consensus $1.00 vs current $1.02